EVIA Life Sciences
EVIA Life Sciences reported $700,002 raised in an SEC Form D filed on 2026-11-02. State of the filing: Japan.
- Industry
- Biotechnology
- Location
- Japan
About
EVIA Life Sciences filed an SEC Form D on 2026-11-02. The filing reports $700,002 raised and gives Japan as the state. The industry on the filing is Biotechnology. Related persons named on the filing: Kosuke Takishima (executive officer, Tokyo, Japan); Joshua Schwab (director, Henderson, Nevada); Michael Kim (director, Henderson, Nevada); Takahiro Ochiya (director, Tokyo, Japan). The legal name on the form is EVIA Life Sciences Inc. Filing: https://www.sec.gov/Archives/edgar/data/2162667/000216266726000001/0002162667-26-000001-index.htm
Year of incorporation on the form: more than five years ago. Securities on the form: equity. That wording is not stored as a round type. Earlier Form D filings, if any, are not combined. The issuer city on the form is Tokyo. It is not stored as a headquarters.
This page is not indexed by search engines yet. A Form D on its own does not name investors or a round type, so the page is promoted once a second source confirms the raise.
Funding history
| Round | Date | Amount | Lead |
|---|---|---|---|
| Form D 2026 | 2026-11-02 | $700K |
Sources
Last verified:
- https://www.sec.gov/Archives/edgar/data/2162667/000216266726000001/0002162667-26-000001-index.htm
Type: sec filing. Accessed 2026-11-03.
SEC Form D for EVIA Life Sciences Inc. EDGAR filing date 2026-11-02. Acceptance time on the index page: 2026-11-02 11:58:45. Signed 2026-11-02 by Kosuke Takishima, Chief Executive Officer. First sale 2026-10-23. A new notice, not an amendment. Total amount sold $700,002 of an offering amount of $5,498,154. 1 investor already invested. Issuer address city is Tokyo, Japan. Jurisdiction on the form: Delaware. Entity type on the form: Corporation. Year of incorporation on the form: more than five years ago. The form does not name the purchasers or a round type. Street addresses and phone numbers are not published. Securities on the form: equity. That wording is not stored as a round type. Related persons use the names in the issue. Earlier Form D filings, if any, are not combined. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-11-03/
Type: other verified public source. Accessed 2026-11-03.
Raise Track Update for 2026-11-03, Section 3. Lists EVIA Life Sciences in Japan, industry Biotechnology, amount raised $700,002.